NET PROFIT (x1000 DKK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-4,425
|
-6,106
|
-10,785 |
| Total assets |
31,602
|
29,659
|
28,911 |
| Current assets |
17,560
|
16,126
|
14,594 |
| Current liabilities |
26,476
|
25,252
|
23,465 |
| Equity capital |
1,500
|
1,500
|
1,500 |
| - share capital |
3,000
|
3,000
|
3,000 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
4.7%
|
5.1%
|
5.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
66.3%
|
63.9%
|
62.2% |
| Return on equity (ROE) |
-295.0%
|
-407.1%
|
-719.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.